SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

DECIPHER LABS

BSE: 524752 28 Jun 2025
Healthcare
₹ 11.05
DECIPHER LABS LIMITED specializes in Pharmaceuticals within the Healthcare sector.

DECIPHER LABS - Share Price & Details

Market Cap
₹11.4
High /Low
20.7 / 9.61
Stock P/E
NA
Book Value
₹8.41
Dividend Yield
0.0
ROCE
-4.98
ROE
₹-5.05
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-27.7
Debt
0.24
CMP / FCF
NA
Debt to equity
₹0.03
NP Ann
-0.44
High price all time
225.0
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
1.01
Net CF
₹0.03
Net profit
-0.44
Price to book value
1.35
Interest Coverage
₹NA
Low price all time
0.1
Industry PE
33.8
Reserves
₹-1.61
Free Cash Flow
₹0.02

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
DECIPHER LABS LIMITEDNANANANA11.4
Cian Healthcare LimitedNANANANA10.3
UNJHA FORMULATIONS LTD.NANANANA10.325.2

Peer Comparison Chart


About DECIPHER LABS

DECIPHER LABS LIMITED, with Security Code 524752, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

DECIPHER LABS Standalone March 2025 Net Sales at Rs 0.23 crore, down 93.27% Y-o-Y

(10 Jun 2025)
Net Sales at Rs 0.23 crore in March 2025 down 93.27% from Rs. 3.36 crore in March 2024. Story continues below Advertisement.
Read more →

DECIPHER LABS Consolidated March 2025 Net Sales at Rs 3.50 crore, down 66.95% Y-o-Y

(03 Jun 2025)
Net Sales at Rs 3.50 crore in March 2025 down 66.95% from Rs. 10.59 crore in March 2024. Story continues below Advertisement.
Read more →

Decipher Labs Faces Valuation Grade Change Amidst Operational Challenges and Market Competition

(03 Jun 2025)
Decipher Labs, a microcap in the Pharmaceuticals and Biotechnology sector, faces significant operational challenges, reflected in its negative financial...
Read more →

DECIPHER LABS REPORTS CONSOLIDATED NET LOSS OF RS 4 11 CRORE IN THE MARCH 2025 QUARTER

(30 May 2025)
Net loss of Decipher Labs reported to Rs 4.11 crore in the quarter ended March 2025 as against net profit of Rs 1.20 crore during the...
Read more →

Decipher Labs Faces Financial Struggles Amid Significant Stock Volatility and Declining Sales

(16 Apr 2025)
Decipher Labs, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a trend of underperformance.
Read more →

Decipher Labs Faces Financial Struggles Amid Significant Stock Volatility and Declining Performance

(27 Mar 2025)
Decipher Labs, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low amid significant volatility and a four-day decline.
Read more →